PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells

Fatty acids may promote type 2 diabetes by altering insulin secretion from pancreatic beta cells, a process known as lipotoxicity. The underlying mechanisms are poorly understood. To test the hypothesis that peroxisome proliferator-activated receptor alpha (PPARalpha) has a direct effect on islet function, we treated INS-1 cells, an insulinoma cell line, with a PPARalpha adenovirus (AdPPARalpha) as well as the PPARalpha agonist clofibric acid. AdPPARalpha-infected INS-1 cells showed PPARalpha agonist- and fatty acid-dependent transactivation of a PPARalpha reporter gene. Treatment with either AdPPARalpha or clofibric acid increased both catalase activity (a marker of peroxisomal proliferation) and palmitate oxidation. AdPPARalpha induced carnitine-palmitoyl transferase-I (CPT-I) mRNA, but had no effect on insulin gene expression. AdPPARalpha treatment increased cellular triglyceride content but clofibric acid did not. Both AdPPARalpha and clofibric acid decreased basal and glucose-stimulated insulin secretion. Despite increasing fatty acid oxidation, AdPPARalpha did not increase cellular ATP content suggesting the stimulation of uncoupled respiration. Consistent with these observations, UCP2 expression doubled in PPARalpha-treated cells. Clofibric acid-induced suppression of glucose-simulated insulin secretion was prevented by the CPT-I inhibitor etomoxir. These data suggest that PPARalpha-stimulated fatty acid oxidation can impair beta cell function.

[1]  T. Scholz,et al.  UCP2-dependent Proton Leak in Isolated Mammalian Mitochondria* , 2002, The Journal of Biological Chemistry.

[2]  D. Kelly,et al.  p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α , 2001, The Journal of Biological Chemistry.

[3]  H. Nawata,et al.  Effects of bezafibrate on β-cell function of rat pancreatic islets , 2001 .

[4]  J. Berger,et al.  Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) α , 2001, The Journal of Biological Chemistry.

[5]  P. Clayton,et al.  Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. , 2001, The Journal of clinical investigation.

[6]  Young-Bum Kim,et al.  Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes , 2001, Cell.

[7]  P. Pennefather,et al.  Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. , 2001, Diabetes.

[8]  K. Capito,et al.  Differential mechanisms of glucose and palmitate in augmentation of insulin secretion in mouse pancreatic islets , 2001, Diabetologia.

[9]  S. Iannello,et al.  Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects. , 2001, Metabolism: clinical and experimental.

[10]  G. Shipley,et al.  Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Unger,et al.  Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. , 2001, Diabetes.

[12]  V. Poitout,et al.  Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. , 2001, Diabetes.

[13]  F. Villarroya,et al.  Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell. , 2001, The Journal of biological chemistry.

[14]  M. Prentki,et al.  Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell* , 2000, The Journal of Biological Chemistry.

[15]  J. Ju,et al.  Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice , 2000, Nature Medicine.

[16]  Sander Kersten,et al.  Roles of PPARs in health and disease , 2000, Nature.

[17]  R. Bergman,et al.  Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. , 2000, Diabetes.

[18]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[19]  M. Mcdaniel,et al.  Relative Hypoglycemia and Hyperinsulinemia in Mice with Heterozygous Lipoprotein Lipase (LPL) Deficiency , 1999, The Journal of Biological Chemistry.

[20]  J. Leahy,et al.  Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets. , 1999, Diabetes.

[21]  M. Prentki,et al.  Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. , 1999, American journal of physiology. Endocrinology and metabolism.

[22]  C. Newgard,et al.  Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. , 1999, Diabetes.

[23]  B. Frohnert,et al.  Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene* , 1999, The Journal of Biological Chemistry.

[24]  D. Kelly,et al.  Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α* , 1998, The Journal of Biological Chemistry.

[25]  C. Wollheim,et al.  Desensitization of Mitochondrial Ca2+ and Insulin Secretion Responses in the Beta Cell* , 1998, The Journal of Biological Chemistry.

[26]  C. Newgard,et al.  Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells , 1998 .

[27]  R. Unger,et al.  Increased Lipogenic Capacity of the Islets of Obese Rats: A Role in the Pathogenesis of NIDDM , 1997, Diabetes.

[28]  M. Prentki,et al.  Fatty Acids Rapidly Induce the Carnitine Palmitoyltransferase I Gene in the Pancreatic β-Cell Line INS-1* , 1997, The Journal of Biological Chemistry.

[29]  J. McGarry,et al.  Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. , 1996, The Journal of clinical investigation.

[30]  Yun-ping Zhou,et al.  A Fatty Acid—Induced Decrease in Pyruvate Dehydrogenase Activity Is an Important Determinant of β-Cell Dysfunction in the Obese Diabetic db/db Mouse , 1996, Diabetes.

[31]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[32]  M. Prentki,et al.  Are the β-Cell Signaling Molecules Malonyl-CoA and Cystolic Long-Chain Acyl-CoA Implicated in Multiple Tissue Defects of Obesity and NIDDM? , 1996, Diabetes.

[33]  J Auwerx,et al.  Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter (*) , 1995, The Journal of Biological Chemistry.

[34]  Yun-ping Zhou,et al.  Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. , 1995, The Journal of clinical endocrinology and metabolism.

[35]  S. Chen,et al.  More Direct Evidence for a Malonyl-CoA–Carnitine Palmitoyltransferase I Interaction as a Key Event in Pancreatic β-Cell Signaling , 1994, Diabetes.

[36]  Yun-ping Zhou,et al.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. , 1994, The Journal of clinical investigation.

[37]  M. Elks.  Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. , 1993, Endocrinology.

[38]  G. Sharp,et al.  Glucose-induced insulin release in islets of young rats: time-dependent potentiation and effects of 2-bromostearate. , 1992, The American journal of physiology.

[39]  J. Foley,et al.  Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus , 1992, Diabetes Care.

[40]  M. Prentki,et al.  Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. , 1992, The Journal of biological chemistry.

[41]  V. Grill,et al.  A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. , 1990, Endocrinology.

[42]  D. Steinberg,et al.  Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. , 1973, The Journal of clinical investigation.

[43]  K. Taylor,et al.  Regulation of Insulin Secretion by Short Chain Fatty Acids , 1968, Nature.

[44]  P. Baudhuin,et al.  Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat-liver tissue. , 1964, The Biochemical journal.

[45]  B. Lowell,et al.  Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. , 2001, Cell.

[46]  J. McGarry,et al.  Fatty acids, lipotoxicity and insulin secretion , 1999, Diabetologia.

[47]  K. Kim,et al.  Essential role of acetyl-CoA carboxylase in the glucose-induced insulin secretion in a pancreatic beta-cell line. , 1998, Cellular signalling.

[48]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C B Wollheim,et al.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. , 1992, Endocrinology.